Macula Society 2022

Characterizing Real-world Functional Outcomes in Patients With Geographic Atrophy: An IRIS Registry Analysis

Impact of the Complement C3 Inhibitor Pegcetacoplan on Photoreceptor Degeneration beyond Areas of Geographic Atrophy in the FILLY Trial

Access Resources

Geographic Atrophy Lesion Growth in Pegcetacoplan-treated Study Eyes Versus Untreated Fellow Eyes in Patients with Bilateral GA in the OAKS, DERBY, and FILLY Trials

Access Resources

Efficacy of Pegcetacoplan in Subgroups Defined by Distance from the Foveal Center Point in the Phase 3 OAKS and DERBY studies of Patients with Geographic Atrophy

Access Resources

Back to Conference Resources

GA Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

Macula Society 2022

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing